Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Ginkgo Bioworks Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference
Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that Co-Founder and CEO, Jason Kelly, is scheduled to present at the 43rd Annual J.
ElevateBio to Present at the 43rd Annual J.P. Morgan Healthcare Conference
ElevateBio is a technology-driven company built to power transformative genetic medicines today and for many decades to come. The Company commercializes its enabling technologies, manufacturing capabilities,
Element Biosciences to Present at 43rd Annual J.P. Morgan Healthcare Conference
Element Biosciences, Inc., a developer of pioneering technologies to empower science, today announced that Element CEO and co-founder Molly He will be presenting a corporate update at the 43rd annual J.
6d
on MSN
J.P. Morgan Loses $39.7 Million Arbitration Against Barred Financial Advisor
The company sought damages against Edward Turley, a former employee who was subject to more than a dozen customer complaints.
Commercial Observer
1d
JP Morgan to Order Staff to Return to Offices Five Days a Week
J.P. Morgan Chase, with about 300,000 employees worldwide, is expected to announce the end of hybrid and remote work in the ...
Modern Healthcare
1d
J.P. Morgan increases security for 2025 conference
The J.P. Morgan Healthcare Conference attracts thousands of attendees each year from the provider, insurance, digital health ...
3d
on MSN
This J.P. Morgan Analyst Is Upbeat About Google. The Stock Is Up.
J.P. Morgan analyst Doug Anmuth said he sees room for Alphabet, Google’s parent, to gain ground on a variety of fronts, ...
Institutional Investor
1d
J.P. Morgan’s Michael Cembalest Predicts Trump “Alchemists” Will Prompt a Correction in 2025
J.P. Morgan Asset Management’s Michael Cembalest calls them “Alchemists” — the Trump White House nominees who are looking to ...
6h
Bank of New York Mellon Corporation (BK) Gets a Buy from J.P. Morgan
J.P. Morgan analyst Vivek Juneja maintained a Buy rating on Bank of New York Mellon Corporation (BK – Research Report) on January 7 and set a ...
BioSpace
1d
Biopharma Heads to JP Morgan Seeking an M&A Spark to Improve Sentiment
M&A didn’t return as hoped for in 2024. The biopharma industry is heading into the J.P. Morgan Healthcare Conference next ...
Pensions&Investments
1d
J.P. Morgan Asset Management bolsters retirement team with former Vestwell, Smart USA execs
Josh Forstater has joined J.P. Morgan Asset Management as managing director, head of Everyday 401 (k), a retirement plan ...
WealthManagement.com
2d
Citi Wealth Hires J.P. Morgan Alum for New Advisory Program Role
Marc Turansky is starting in the newly-created role of head of investment advisory programs as of Monday, according to Keith Glenfield, head of investment solutions.
3d
Novo Nordisk (0QIU) Gets a Buy from J.P. Morgan
J.P. Morgan analyst Richard Vosser maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of ...
STAT
1d
With a major patent cliff coming, will JPM play host to some serious deal-making?
The drug industry is facing one of the largest patent cliffs in recent history. Will that mean dealmaking at the annual J.P.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback